A5020142922- Respiratory and Cough-Related Research
- Gastroesophageal reflux and treatments
- Opioid Use Disorder Treatment
- Radiology practices and education
- Dysphagia Assessment and Management
- Pain Management and Opioid Use
- Anesthesia and Pain Management
- Innovations in Medical Education
- Advances in Oncology and Radiotherapy
- Eosinophilic Esophagitis
Medical College of Wisconsin
2022-2024
Milwaukee VA Medical Center
2022
Objectives Mean nocturnal baseline impedance (MNBI) is a measure of the esophageal epithelial barrier function calculated via high‐resolution manometry and can be used as diagnostic tool treatment response predictor for gastroesophageal reflux disease (GERD). However, its utility laryngopharyngeal (LPR) has been minimally studied. We aimed to investigate relationship MNBI between patients with suspected LPR, healthy controls, their 24‐h multichannel intraluminal impedance‐pH (MII‐pH) study...
Objective To evaluate the efficacy of distal esophageal mean nocturnal baseline impedance (MNBI), a general marker mucosal barrier integrity, in predicting laryngopharyngeal reflux (LPR) and symptomatic response to acid therapy. Methods This retrospective study analyzed 173 patients who presented with symptoms underwent 24‐h multichannel intraluminal impedance‐pH (MII‐pH) testing. Mean values were calculated assessed for their association ability predict LPR symptoms, MII‐pH results,...